FDA Investigator Michelle M Noe

Michelle M Noe has inspections in 9 countries as of 13 Oct 2023. Michelle M Noe has collaborated with a combinined 5156 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
227
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100003979
Country:
United States of America, France, Poland, South Africa, Finland, Canada, Germany, Hungary, India
Co-Investigator(s):
Aaron L Morris, Abby E Pelletier, Abthony C Warchut, Aimee Cunningham, PhD, Aldo J Quintana, Alexandra B Pitkin, Alice C Silva, Allen F Hall, Allison A Rodriguez, Almaris N Alonso, Alois P Provost, Alysia M Salonia, Amanda E Lewin, PhD, Amber G Wardwell, Amy C Jordan, Amy Devlin, PhD, Andrea A Branche, Andrew M Barlow, Andrew P Abban, Anissa M Cheung, Anne E Carpenter, Anthony C Warchut, Anthony N Onianwa, Anthony P Costello, Anthony W Thomas, Arie C Menachem, Ashley M Whitehurst, Atricia L Irons, Betsy C Galliher, Bill Tacket, Jr, Bradley D Newsad, Brenda P King, Brenna L Macdowell, Brentley S Collins, Brently S Collins, Bruce R Ota, Burnell M Henry, Byungja E Marciante, Carl A Huffman, III, Carla C Tuite, Cassandra L Abellard, Charles Yuanchia Kuo, PhD, Christian D Lynch (CDL), Christina Capacci Daniel, PhD, Christine L Williams, Christine M Smith, Christopher A Demitrius, Christopher Downey, PhD, Christopher Janik, Christopher K Vantwuyver, Christopher M Elliott, Chunsheng Cai, PhD, Clinton V Giustra, Constance Desimone, Courtney N Long, Craig A Garmendia, Cynthia F Kleppinger, MD, Dana A Razzano, Danielle S Pearson, Darin S Wiegers, Daryl A Dewoskin, David M Lamoureux, David P Vanhouten, David R Heiar, David Van Houten, Dawn C Olenjack, Dawn M Braswell, Deborah A Greco, Diane C Thibodeau, Dien N Nguyen, Douglas Florentino, Douglas S Joslin, Dr. Sriram Subramaniam, PhD, Edmund F Mrak, Jr, Edward J Janik, Ekaterina Allen, Elise L Mcdevitt, Elizabeth B Griffin, Elizabeth Ll Edwards, Ellen P Madigan, Emily J Schramm, Eric C Schmitt, Erich P Garger, Erik W Koester, Erin P Conlin, Felix Maldonado, Frank J Koch, Gabrielle J Swain, Gajendiran Mahadevan, PhD, Garry H Stewart, Gary J Hagan, Gena M Mckahan, Gene D Arcy, George T Allen, Jr, Gerald N Mcgirl, DDS, Gerard D Difiore, Gordon, Gunther Bockhoudt, Gunther Boekhoudt, PhD, Haley H Seymour, Hang N Guo, Harperd, Hien Albright, Himanshu Gupta, PhD, Intkhab H Wahla, Irons, Isaac K Carney, Jackson Y See, James H Tanner, James P Finn, James W Whitney, Jamie S Mathews, Janete F Guardia, Jason A Rossi, Jay M Patria, Jayaleka J Amarasinghe, Jee Chung, PhD, Jeffrey J Thibodeau, Jeffrey S Buckser, Jessica D Spellman, Jessica I Newman, John A Sciacchitano, John D White, John J Thibodeau, John L Zaccone, John P Mistler, John P Shelton, John R Carlson, John S Hartford, Jonah S Ufferfilge, Jonathan B Lewis, Jonathan G Matrisciano, Jonee J Mearns, Jose A Torres, Joseph B Cascio, Joseph Foley, Joseph H Procopio, Joseph T Frost, Joshua L Gibbs, Joyce A Kellett, Joyce A Rockwell, Joyce A Williams, Juan C Gonzalez, Julie D Bringger, Justine M Corson, Ka L Wong, Kara A Scheibner, PhD, Karen L Kosar, Karen Mcnabb Noon, Kathleen A Sousa, Kathleen E Mcafoose, Kathleen M Curry, Kathleen R Jones, PhD, Kathryn A Krentz, Kenneth H Williams, Kent A Conforti, Kimberly J Langello, Kip J Hanks, Kristina J Donohue, Kyle J Spencer, Lauren M Lawrance, LCDR Debra Emerson, Leo B Zadecky, Liz M Otero, Lorayne A Mcguinness, Louis Christy, Lynne M Dwyer, M Patriciaurphy Murphy, Margaret E Walsh, Margaret M Sands, Maria Pkelly Doggett, MBA, Mark A Heard, Mark E Farrell, Mark R Mcclain, Martha T Olone, Martin J Guardia, Mary Jeanet Mcgarry, Maryam Tabatabaie, Matthew C Watson, Maxwell Van Tassell, PhD, Maya M Davis, Mclaughlin, Megan A Haggerty, Melissa N Gregorio, Miah Jung, Michael E Marcarelli, Michael F Skelly, PhD, Michael J Casey, Michael L Casner, Michael P Anthony, Michael P Sweeney, Michelle M Moe, Michelle M Noe Varga, Michelle Rfrazier Jessen, PhD, Mikayla K Deardorff, Monique C Lo, Mutahar S Shamsi, Nabil Nakhoul, Nadeem I Chaudhry, Nailing Zhang, Nasser Yazdani, Nealie C Newberger, Nicholas B Murphy, Nicholas E Stuhr, Nichole B Murphy, Nicola M Fenty Stewart, Nina Yang, Osama A Khatib, Pamela L Lee, Pamela L Ogonowski, Paraluman S Leonin, Patricia Fhughes Troost, Patrick M Regan, Paul L Yeh, Paul P Geraci, Paula A Trost, Paula M Laplant, Peter R Lenahan, Philip H Lafleur, Philip Kreiter, Phillip E Mclaughlin, Prabhu P Raju, Priscilla M Pastrana, Rachael O Oyewole, Ramcharan S Khalsa, Ramon E Martinez, Rapti D Madurawe, Rebecca A Coleman, Remal, Richard F Hapke, Richard H Penta, Richard L Friedman, Richard L Licari, Richard W Thornton, Robert D Ogan, Robert E Moncayo, Robert J Martin, Robert Mo Brien, Rory K Geyer, Rupa Pradhan, Sandra P White, Sara M Onyango, Scott B Laufenberg, Scott C Lute, Scott Lute, Sean M Tessicini, Sean R Marcsisin, Seth A Mailhot, Sharon K Gershon, Shawn M Bogdan, Sherri N Rohlf, MD, Simone E Pitts, Slater K Bartlett, Sripal R Mada, PhD, Stacey S Degarmo, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephen C Smith, Stephen R Souza, Steven M Ferrara, Sunita Pandey, Susan D Yuscius, Susanne M Richardson, MSc RAC ELS, Suzanne M Healy, Tania K Mercado, Teddy Tom, Thomas Cote, Thomas H Jenkins, Thomas J Arista, Thomas J Kelly, Thomas J Murphy, Thomas O Morgan, Thomas Siebertz, Thomas W Nerney, Timothy M Glod, Troy R Petrillo, Victor J Gangi, Victoria M Daddeo, Victoria Taylor, Walter Lange, Wayne E Seifert, Wendy A Johnecheck, William K Dagley, Xiaokuang Lai, PhD, Yanming An, PhD, Zhihao Qiu (Peter), PhD, Zhongren Wu

Michelle M Noe's Documents

Publish Date Document Type Title
April, 2008 EIR Charles J. Cote, MD - EIR, 2008-04-30
May, 2014 FDA 483 Robert J. Weiss, M.D. - Form 483, 2014-05-12
June, 2012 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2012-05-07
January, 2007 FDA 483 Dr. Remo Panaccione-University of Calgary - Form 483, 2007-01-26
May, 2014 EIR Robert J. Weiss, M.D. - EIR, 2014-05-12
April, 2008 FDA 483 Charles J. Cote, MD - Form 483, 2008-04-30
March, 2005 FDA 483 Stephen Rossner - Form 483, 2005-03-10
September, 2010 EIR Boehringer Ingelheim Pharmaceuticals, Inc. - EIR, 2010-09-01
June, 2012 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2012-06-06
June, 2009 FDA 483 Pfizer Inc. - Form 483, 2009-06-03
October, 2013 EIR Moussa C. Mansour, MD - EIR, 2013-10-15
April, 2008 FDA 483 Response Charles J. Cote, MD - Form 483R, 2008-04-30
March, 2005 EIR Stephen Rossner - EIR, 2005-03-10
September, 2008 FDA 483 Response Ameridose, LLC - Form 483R, 2008-12-09
January, 2010 FDA 483 Shire Human Genetics Therapies, Inc. - Form 483, 2010-01-07
July, 2014 FDA 483 Response Emerson Hospital Human Rights Committee - Form 483R, 2014-08-04
April, 2004 EIR First Boston Pharma LLC - EIR, 2004-04-20
September, 2008 EIR Ameridose, LLC - EIR, 2008-09-18
June, 2009 EIR Pfizer Inc. - EIR, 2009-06-03
July, 2014 FDA 483 Emerson Hospital Human Rights Committee - Form 483, 2014-07-24
March, 2015 FDA 483 Andrea L. D. Orsey, M.D. - Form 483, 2015-03-24
September, 2010 FDA 483 Response Boehringer Ingelheim Pharmaceuticals, Inc. - Form 483R, 2010-09-14
July, 2014 EIR Emerson Hospital Human Rights Committee - EIR, 2014-07-24
September, 2003 EIR The Superior Nut Company, Inc. - EIR, 2003-09-30
November, 2007 FDA 483 Tedor Pharma Inc. - Form 483, 2007-11-08
October, 2013 FDA 483 Response Moussa C. Mansour, MD - Form 483R, 2013-11-04
September, 2003 FDA 483 Response The Superior Nut Company, Inc. - Form 483R, 2003-10-07

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more